Working… Menu
Trial record 2 of 8 for:    ponatinib | Leukemia, Myeloid | Italy

Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia (CarPAs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04709731
Recruitment Status : Not yet recruiting
First Posted : January 14, 2021
Last Update Posted : February 3, 2021
Information provided by (Responsible Party):
Associazione Italiana Pazienti Leucemia Mieloide Cronica

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : October 31, 2024
Estimated Study Completion Date : April 1, 2025